Obsessive-Compulsive Disorder – Epidemiology – Mature Markets

Clarivate Epidemiology’s coverage of obsessive-compulsive disorder (OCD) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan). We report the total 12-month prevalence and the severity of OCD for each country, as well as annualized case counts projected to the national population.

Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets.

Clarivate Epidemiology’s OCD forecast will answer the following question:

  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of OCD over the forecast period?

All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

Clarivate Epidemiology provides at least 10 years of forecast data for the following OCD patient populations:

  • Total 12-month prevalent cases.
  • Total 12-month prevalent cases by severity—mild, moderate, severe.

Note: Coverage may vary by country and region.

Table of contents

  • Obsessive-Compulsive Disorder - Epidemiology - Mature Markets
    • Epidemiology data
    • Methods
      • Literature review (studies included in/excluded from the analyses of obsessive-compulsive disorder)
      • Total OCD 12-month prevalent cases
      • Total OCD 12-month prevalent cases by severity
      • Risk / protective factors applied to disease forecast models
    • Reference materials
      • Bibliography
      • Glossary
      • Abbreviation Table

Login to access report